|
COPZ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00599995001005E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.85249999959692E-07 |
| Normal-vs-Stage2 |
9.903000E-03 |
| Normal-vs-Stage3 |
5.567800E-04 |
| Normal-vs-Stage4 |
8.118500E-03 |
| Stage1-vs-Stage2 |
9.429000E-01 |
| Stage1-vs-Stage3 |
2.474400E-01 |
| Stage1-vs-Stage4 |
1.096810E-01 |
| Stage2-vs-Stage3 |
4.525000E-01 |
| Stage2-vs-Stage4 |
1.928410E-01 |
| Stage3-vs-Stage4 |
4.986200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.9519000294419E-09 |
| Normal-vs-AfricanAmerican |
7.3909999998012E-07 |
| Normal-vs-Asian |
4.365200E-01 |
| Caucasian-vs-AfricanAmerican |
6.475000E-01 |
| Caucasian-vs-Asian |
5.038400E-01 |
| AfricanAmerican-vs-Asian |
3.899600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.51949999752199E-08 |
| Normal-vs-Female |
5.61370000484729E-08 |
| Male-vs-Female |
9.054300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.238270E-03 |
| Normal-vs-Extreme_Weight |
5.88240000000129E-05 |
| Normal-vs-Obese |
1.47810000017401E-07 |
| Normal-vs-Extreme_Obese |
3.664000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.032800E-01 |
| Normal_Weight-vs-Obese |
7.378000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.264600E-01 |
| Extreme_Weight-vs-Obese |
3.598400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.599200E-01 |
| Obese-vs-Extreme_Obese |
1.079790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.10540004822002E-09 |
| Normal-vs-Age(41-60Yrs) |
1.01770003535506E-09 |
| Normal-vs-Age(61-80Yrs) |
1.55365999999768E-05 |
| Normal-vs-Age(81-100Yrs) |
1.070620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.836300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.198600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.761700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.928400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.377200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.305000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.746100345012E-10 |
| Normal-VS-Type2 PRCC |
8.821900E-04 |
| Normal-VS-KIRP CIMP |
1.153760E-04 |
| Normal-VS-Unclassified PRCC |
1.820080E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.848400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.022000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.902400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.928000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.241700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.087400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.917240E-03 |
| Normal-vs-N1 |
6.19359999999292E-05 |
| Normal-vs-N2 |
2.25159890732129E-11 |
| N0-vs-N1 |
1.331240E-01 |
| N0-vs-N2 |
2.021700E-03 |
| N1-vs-N2 |
7.462900E-03 |
|
|
